Si-Bone Inc

Si-Bone Inc

SIBN · NASDAQ · Healthcare / Medical Devices

23.44USD-0.70 (-2.90%)

Price History

Full chart

Market Stats

Previous Close24.14
Open24.40
Day Range23.40 – 24.68
52-Week Range11.48 – 21.89
Volume443.69K
Market Cap840.80M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.33
Dividend Yield0.00%
Beta0.70
50-Day Avg18.50
200-Day Avg16.34

About

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Laura A. Francis MBA
  • Employees376
  • Headquarters471 El Camino Real, Santa Clara, CA, United States, 95050, USA
  • Websitehttps://si-bone.com

Leadership

  • Mr. Jeffrey W. DunnExecutive Chairman · b. 1956
  • Ms. Laura A. Francis MBACEO & Director · b. 1967
  • Mr. Anshul MaheshwariCOO & CFO · b. 1980
  • Mr. Michael A. Pisetsky J.D.Chief Business & Legal Affairs Officer, Secretary and General Counsel
  • Mr. Anthony J. RecuperoAdvisor · b. 1960
  • Dr. Scott A. Yerby Ph.D.Senior VP of Engineering & CTO · b. 1968
  • Mr. Saqib IqbalVice President of Financial Planning & Analysis and Investor Relations
  • Mr. Ian BaileyVice President of Product & Marketing
  • Dr. Daniel Joseph Cher M.D.Senior Vice President of Clinical, Regulatory Affairs & Quality · b. 1965
  • Dr. W. Carlton Reckling M.D.Chief Medical Officer & VP of Medical Affairs · b. 1963

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.02M49.00M40.05M41.17M42.10M47.98M55.38M67.30M73.39M90.15M106.41M138.89M167.18M200.93M
Growth (%)-+32.37%-18.26%+2.79%+2.25%+13.97%+15.42%+21.53%+9.04%+22.84%+18.03%+30.52%+20.37%+20.19%
Cost of Revenue3.04M4.33M6.50M5.40M5.17M5.11M4.83M6.79M8.90M10.43M15.71M29.47M35.06M41.05M
Gross Profit33.98M44.67M33.55M35.77M36.94M42.87M50.55M60.51M64.48M79.72M90.70M109.42M132.12M159.88M
Gross Margin91.78%91.16%83.77%86.89%87.73%89.35%91.27%89.91%87.87%88.43%85.24%78.78%79.03%79.57%
Operating Expense44.69M49.96M59.85M62.20M54.50M60.22M62.51M96.51M103.05M131.39M150.31M156.35M167.37M182.21M
Operating Income-10.72M-5.30M-26.30M-26.42M-17.57M-17.35M-11.96M-36.00M-38.57M-51.67M-59.61M-46.93M-35.25M-22.33M
Operating Margin-28.96%-10.81%-65.66%-64.18%-41.72%-36.16%-21.61%-53.50%-52.55%-57.31%-56.02%-33.79%-21.08%-11.11%
EBITDA-10.68M-5.25M-26.01M-25.68M-16.24M-15.82M-11.24M-32.68M-36.47M-50.97M-54.98M-34.45M-23.09M-10.91M
EBITDA Margin-28.84%-10.71%-64.95%-62.38%-38.58%-32.97%-20.30%-48.56%-49.69%-56.54%-51.67%-24.80%-13.81%-5.43%
Net Income-10.90M-6.15M-27.81M-28.15M-20.59M-23.04M-17.45M-38.40M-43.70M-56.57M-61.26M-43.34M-30.91M-18.91M
Net Income Margin-29.45%-12.56%-69.42%-68.38%-48.90%-48.01%-31.51%-57.06%-59.54%-62.75%-57.57%-31.20%-18.49%-9.41%
R&D3.77M8.37M9.17M8.61M6.38M5.51M5.38M7.28M9.46M12.44M13.63M15.03M16.56M17.45M
R&D as % of Total Revenue10.18%17.09%22.90%20.90%15.15%11.49%9.71%10.82%12.89%13.80%12.81%10.82%9.91%8.68%
Interest Expense--003.31M6.20M5.49M4.95M6.10M5.37M2.82M3.46M3.44M5.28M
Interest Expense % of Total Revenue--0.00%0.00%7.86%12.93%9.91%7.35%8.31%5.95%2.65%2.49%2.06%2.63%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-18.01M28.98M36.05M39.44M35.83M138.52M117.01M223.14M190.51M157.55M230.43M230.44M238.56M
Total Liabilities-19.67M22.09M32.82M148.17M165.21M48.33M54.00M53.78M56.09M59.25M61.05M63.47M61.02M
Total Equity--1.65M6.89M3.23M-108.73M-129.38M90.19M63.01M169.36M134.42M98.30M169.38M166.96M177.53M
Cash-8.52M17.60M20.27M27.90M22.41M25.12M10.44M53.58M63.42M20.72M33.27M34.95M42.24M
Total Debt-11.68M15.15M25.06M29.90M77.83M38.96M39.22M39.45M40.48M39.43M38.99M37.48M1.12M
Net Debt-3.17M-2.45M4.78M1.41M16.30M13.84M28.79M-14.13M-22.94M18.71M5.72M2.54M-41.12M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-14.76M-566.00K-26.33M-26.72M-16.75M-17.53M-14.52M-31.63M-30.66M-39.53M-41.66M-18.71M-12.43M-675.00K
Investing Cash Flow-39.00K-735.00K-2.87M-2.24M-441.00K-478.00K-97.83M13.49M-62.92M51.58M-2.81M-59.80M12.62M4.16M
Financing Cash Flow4.05M8.06M38.09M31.38M24.75M12.86M115.15M3.49M136.40M-1.71M2.20M90.93M1.96M3.38M
Capital Expenditure39.00K735.00K2.87M2.24M441.00K478.00K942.00K2.44M2.56M6.39M9.51M7.80M10.50M8.41M
Free Cash Flow-14.80M-1.30M-29.20M-28.96M-17.19M-18.01M-15.46M-34.07M-33.22M-45.92M-51.16M-26.51M-22.92M-9.09M
Dividends Paid--------1.92M4.91M-2.15M--
FCF to OCF100.26%229.86%110.90%108.38%102.63%102.73%106.49%107.73%108.35%116.16%122.82%141.68%184.48%1346.52%
Dividend Paid to FCF---------5.76%-10.69%--8.11%--

Earnings

Report DateMay 24, 2017Aug 29, 2018Nov 29, 2018Mar 7, 2019May 8, 2019Aug 6, 2019Nov 10, 2019Mar 9, 2020May 4, 2020Aug 3, 2020Nov 3, 2020Mar 8, 2021May 3, 2021Aug 2, 2021Nov 8, 2021Feb 28, 2022May 9, 2022Aug 8, 2022Nov 7, 2022Feb 27, 2023May 1, 2023Aug 7, 2023Nov 6, 2023Feb 26, 2024May 6, 2024Aug 5, 2024Nov 12, 2024Feb 24, 2025May 5, 2025Aug 4, 2025Nov 10, 2025Feb 23, 2026May 11, 2026Aug 3, 2026Nov 9, 2026
EPS Estimate0.000.00-0.28-0.21-0.25-0.35-0.37-0.35-0.38-0.63-0.42-0.30-0.39-0.39-0.41-0.39-0.43-0.49-0.47-0.40-0.42-0.40-0.34-0.28-0.31-0.28-0.24-0.13-0.22-0.18-0.16-0.13-0.19-0.15-0.13
EPS Actual-0.30-0.19-0.30-0.22-0.38-0.35-0.46-0.36-0.47-0.44-0.33-0.28-0.37-0.42-0.48-0.43-0.52-0.54-0.41-0.32-0.32-0.30-0.25-0.27-0.27-0.22-0.16-0.11-0.15-0.14-0.11-0.04-0.10-0.09-
Surprise---7.14%-4.76%-52.00%0.00%-24.32%-2.86%-23.68%30.16%21.43%6.67%5.13%-7.69%-17.07%-10.26%-20.93%-10.20%12.77%20.00%23.81%25.00%26.47%3.57%12.90%21.43%33.33%18.09%31.82%22.22%31.25%69.23%47.37%40.00%-
Timing--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap840.80M
Enterprise Value731.38M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.90
Price / Book4.62
EPS-0.33
Book Value4.08
Revenue (TTM)213.60M
Gross Profit (TTM)169.87M
EBITDA-11.32M
Profit Margin-6.85%
Operating Margin-8.58%
Return on Equity-8.30%
Return on Assets-4.62%
Shares Outstanding44.82M
Shares Float39.99M
Beta0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 9 analystsTarget 25.00
  • Strong Buy
    5
  • Buy
    4

Ownership Breakdown

Institutions
109.54%
Insiders
3.27%
Retail / Other
0.00%

Top Institutional Holders

  • First Light Asset Management, LLC
    8.13M18.14%
  • BlackRock Inc
    3.43M7.65%
  • Cadian Capital Management LP
    3.35M7.47%
  • American Century Companies Inc
    2.51M5.60%
  • Brown Advisory Holdings Inc
    2.12M4.74%
  • Vanguard Capital Management, LLC
    1.76M3.94%
  • Granahan Investment Management Inc..
    1.74M3.88%
  • Arnhold & S. Bleichroeder Advisers, LLC
    1.54M3.43%
  • Impax Asset Management Group PLC
    1.43M3.18%
  • Nuveen, LLC
    1.29M2.87%
  • Silvercrest Asset Management Group LLC
    1.24M2.78%
  • Paradigm Capital Management, Inc.
    1.23M2.75%
  • State Street Corp
    1.13M2.52%
  • Gilder Gagnon Howe & CO LLC
    1.05M2.34%
  • Geode Capital Management, LLC
    951.73K2.12%
  • Champlain Investment Partners, LLC
    896.46K2.00%

Top Fund Holders

  • American Century Small Cap Growth Inv
    1.90M4.23%
  • Impax Small Cap Institutional
    1.43M3.18%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.34M2.98%
  • iShares Russell 2000 ETF
    1.12M2.51%